← Open Payments lookup

ERIN MUNOZ: Open Payments

NPI 1144519927 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,180 in 58 payments from 22 companies in 2025. Trend: 2023 $1,478 · 2024 $628 · 2025 $1,180

Food & beverage: $1,180
CompanyPaymentsAmount
ABBVIE INC.12$168
Neurocrine BioSciences, Inc.4$140
Novo Nordisk Inc4$93
Bayer Healthcare Pharmaceuticals Inc.3$83
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$81
Aimmune Therapeutics, Inc.3$66
VIVUS LLC3$65
TOLMAR, INC.3$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$57
Vanda Pharmaceuticals Inc.3$53

Products named: INGREZZA, VRAYLAR, Kerendia, CAPLYTA, ZENPEP, PANCREAZE, JATENZO, XIFAXAN.

Industry payments across TX — which companies pay providers there.